multivessel disease revascularisation: balancing the risk - europcr 2021
Published 3 years ago • 3.5K plays • Length 59:16Download video MP4
Download video MP3
Similar videos
-
45:56
importance of extensive revascularisation and timing of mcs - europcr 2021
-
5:05
complete revascularization in patients with acute myocardial infarction - europcr 2021
-
45:19
physiologic guidance and optimisation in multivessel disease - europcr 2023
-
6:05
multivessel disease: which patients for pci, cabg or medical treatment? - europcr 2023
-
57:37
a case-based approach: finding balance between bleeding and ischemic risk - europcr 2021
-
4:16
ffr-guided pci optimisation directed by high-definition ivus - europcr 2021
-
56:29
complete revascularisation: from defining pci strategy to pci optimisation - gulfpcr-gim 2021
-
44:19
stemi: is opsens optowire iii a game-changer in complete revascularization? - europcr 2021
-
16:25
ebc main overview and the impact to clinical practice - europcr 2021
-
6:02
biostemi: translating ultrathin des technology into superior stemi patient outcomes - europcr 2021
-
44:00
the challenge of the diabetic patient with diffuse coronary artery disease - europcr 2022
-
44:54
where deliverability matters: challenging cases requiring a low profile - europcr 2021
-
4:48
the future and vision of intravascular imaging - europcr 2021
-
14:24
timing and indication for pci in tavi patients with coronary disease - europcr 2021
-
38:54
completeness of revascularisation in acute coronary syndrome patients with multivessel disease
-
45:12
redefining hypertension management with renal denervation - europcr 2021
-
54:41
revascularization for multivessel coronary disease: pci or cabg? (w. f. fearon md) november 18, 2021
-
12:36
is cusp overlap technique the standard of care? - europcr 2021
-
1:25:12
the synergy stent: complete revascularisation solutions in complex pci